Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v1-EN
Language English English
Date Updated 2023-01-26 2022-08-23
Drug Identification Number 02467135 02467135
Brand name ONIVYDE ONIVYDE
Common or Proper name Onivyde Onivyde
Company Name IPSEN BIOPHARMACEUTICALS CANADA INC IPSEN BIOPHARMACEUTICALS CANADA INC
Ingredients IRINOTECAN IRINOTECAN
Strength(s) 4.3MG 4.3MG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 10mL 10mL
ATC code L01CE L01CE
ATC description
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2022-08-19 2022-08-19
Estimated end date Unknown
Actual end date 2023-01-25
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments